tallózása szerző szerint "Müller, Judit"

21-40 / 41

Gyermekkori non-Hodgkin-lymphoma kezelésével szerzett magyarországi tapasztalatok [Hungarian experience with non-Hodgkin's lymphoma in childhood]

Müller, Judit; Csóka, Monika; Jakab, Zsuzsanna; Ponyi, Andrea; Erlaky, Hajna; Magyar Gyermekonkológiai Hálózat; Kovács, Gábor (2006)

Between 1990 and 2004, 230 children with non-Hodgkin's lymphoma (NHL) were treated according to the Berlin-Frankfurt-Munster (BFM) protocols (NHL-BFM-90 and -95) in Hungary. The aim of the present study was to summarize ...
Hodgkin-lymphoma adolescens korban. Hol érdemes kezelni: felnőtt- vagy gyermekintézményben?

Müller, Judit; Molnar Z; Illés, Árpád; Csóka, Monika; Jakab, Zsuzsanna; Deak B; Schneider T; Varady E; Rosta A; Simon, Zsófia; Keresztes K; Gergely, Lajos; Kovács, Gábor (2008)

Adolescent patients with Hodgkin's lymphoma (HL) are treated either in pediatric, or in adult oncological wards. AIM: The aim of our work was to compare the treatment modalities and the survival rates in adolescents with ...
Incidence and Survival of Central Nervous System Involvment in Childhood Malignancies: Hungarian Experience

Hauser, Péter; Jakab, Zsuzsanna; Láng, Orsolya; Kondás O; Müller, Judit; Schuler, Dezső; Bognár, László; Garami, Miklós (2005)

Direct extension and hematogenous metastasis of primary non-CNS malignant tumors to the CNS are rare complications in children. The authors analyzed the incidence and outcome of these complications in Hungary. During ...
Late immune recovery in children treated for malignant diseases

Kovács, Gábor; Barany O; Schlick B; Csóka, Monika; Gado J; Ponyi, Andrea; Müller, Judit; Nemeth J; Hauser, Péter; Erdélyi, Dániel (2008)

In this study we analyzed the recovery of the immune system in children after completion of the therapy. We analysed 88 children (51 boys, 37 girls, mean age at diagnosis: 7.8 years) receiving chemotherapy for malignant ...
Lymphomák adoleszcens korban: Érdemes-e gyermek-protokollal kezelni ezt a betegcsoportot?

Bence, Zsófia; Kovács, G; Jakab, Zsuzsanna; Csóka, Monika; Müller, Judit (2008)
Lymphomák adoleszcens korban: Érdemes-e gyermek-protokollal kezelni ezt a betegcsoportot?

Bence, Zsófia; Kovács, Gábor; Jakab, Zsuzsanna; Csóka, Monika; Müller, Judit (2008)
Malignus hematológiai betegségek tünettana és kezelése gyermekkorban

Kovács, Gábor; Müller, Judit; Erdélyi, Dániel; Csóka, Monika (2014)
Meropenem in the Treatment of Febrile Neutropenic Children

Müller, Judit; Garami, Miklós; Constantin, Tamás; Schmidt, Marianne; Fekete, György; Kovács, Gábor (2005)

The aim of this retrospective study was to evaluate the clinical effectiveness of meropenem in immunocompromised children. Between January 1998 and December 2002 in the hemato-oncological units of our hospital meropenem ...
MicroRNA-181a as novel liquid biopsy marker of central nervous system involvement in pediatric acute lymphoblastic leukemia

Egyed, Bálint; Kutszegi, Nóra; C. Sági, Judit; Gézsi, András; Rzepiel, Andrea; Visnovitz, Tamás; Lőrincz, Péter; Müller, Judit; Zombori, Marianna; Szalai, Csaba; Erdélyi, Dániel; Kovács, Gábor; Semsei F, Ágnes (2020)
„Minimális reziduális betegség” – Egy fontos új fogalom

Erdélyi, Dániel; Müller, Judit; Kovács, Gábor (2013)
National Registry of Patients with Juvenile Idiopathic Inflammatory Myopathies in Hungary – Clinical Characteristicteristics and Disease Course of 44 Patients with Juvenile Dermatomyositis

Constantin, Tamás; Ponyi, Andrea; Orbán I; Molnár K; Dérfalvi, Beáta; Dicső F; Kálovics, Tamás; Müller, Judit; Garami, Miklós; Sallai, Ágnes; Balogh, Zsolt; Szalai, Zsuzsanna Zsófia; Fekete, György; Dankó, Katalin (2006)

Idiopathic inflammatory myopathies (IIMs) are systemic autoimmune diseases characterized by chronic muscle inflammation resulting in progressive weakness and frequent involvement of internal organs, mainly the ...
Neutropeniás gyermekek leggyakoribb fertőzései és a kezelés lehetőségei

Müller, Judit; Kovács, Gábor; Schmidt, Marianne; Fekete, György (2000)
Nyirokcsomó-megnagyobbodás – mikor kell malignitásra gondolni?

Erdélyi, Dániel; Müller, Judit; Kovács, Gábor (2015)
Our Experiences with Asparaginase Activity Measurements in Children with Lymphoblastic Diseases

Müller, Judit; Egyed, Petra; Erdélyi, Dániel; Kovács, Krisztián; Mudra, Katalin; Szabó, Sándor; Egyed, Bálint; Gábor, Kovács (2023)

Background: Asparaginase is a key component of chemotherapy protocols for the treatment of lymphoblastic malignancies among children. Adequate asparagine depletion is an important factor to achieve optimal therapeutic ...
Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma.

Hegyi, Márta; Arany, Ádám; Semsei, Ágnes F; Csordas, Katalin; Eipel, Olivér; Gézsi, András; Kutszegi, Nóra; Csóka, Monika; Müller, Judit; Erdélyi, Dániel; Antal, Péter; Szalai, Csaba; Kovács, Gábor (2017)

Inter-individual differences in toxic symptoms and pharmacokinetics of high-dose methotrexate (MTX) treatment may be caused by genetic variants in the MTX pathway. Correlations between polymorphisms and pharmacokinetic ...
SHMT1 1420 and MTHFR 677 variants are associated with rectal but not colon cancer.

Komlósi, Lajos Viktor; Hitre, Erika; Pap E; Adleff V; Réti, Andrea; Székely, Éva; Biro A; Rudnai P; Schoket B; Müller, Judit; Tóth, Béla; Szabolcs, Ottó; Kásler, Miklós; Kralovánszky, Judit; Budai, Barna (2010)

BACKGROUND: Association between rectal or colon cancer risk and serine hydroxymethyltransferase 1 (SHMT1) C1420T or methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms was assessed. The serum total homocysteine ...
Subacute cardiotoxicity caused by anthracycline therapy in children

Kovács, Gábor; Erlaky, Hajna; Toth K; Horvath E; Szabolcs, Judit; Csóka, Monika; Jokuti L; Erdélyi, Dániel; Müller, Judit (2007)
Toxic encephalopathy and delayed MTX clearance after high-dose methotrexate therapy in a child homozygous for the MTHFR C677T polymorphism.

Müller, Judit; Kralovánszky, Judit; Adleff V; Pap E; Németh, Krisztina; Komlósi, Lajos Viktor; Kovács, Gábor (2008)

BACKGROUND: High-dose methotrexate (HD-MTX) is one of the most important agents in the therapy of osteosarcoma (OSC). Acute and delayed toxicities still constitute clinical problems. Methylenetetrahydrofolate reductase ...
Treatment of pediatric non-Hodgkin lymphoma in Hungary: 15 years experience with NHL-BFM 90 and 95 protocols

Müller, Judit; Csóka, Monika; Jakab, Zsuzsanna; Ponyi, Andrea; Erlaky, Hajna; Kovács, Gábor (2008)

Retrospective analysis was performed to assess the survival-rates of children with non-Hodgkin lymphoma (NHL), treated according to the NHL-BFM (Berlin-Frankfurt-Munster)-90 and -95 protocols between 1990 and 2004 in ...
Új és hagyományos irányok a gyermekkori akut lymphoblastos leukaemia biológiájában és ellátásában

Egyed B; Kovács, Gábor; Kutszegi, Nóra; Rzepiel A; C. Sági, Judit; Erdélyi, Dániel; Müller, Judit; Semsei, Ágnes F (2018)

Owing to clinical trials and improvement over the past few decades, the majority of children with acute lymphoblastic leukemia (ALL) survive by first-line chemotherapy and combat with the problems of returning to community. ...

21-40 / 41

Keresés

Összetett keresés

Tallózás

Teljes repozitórumban

Hozzáférésem

Bejelentkezés

tallózása szerző szerint "Müller, Judit"

DSpace/Manakin Repository

tallózása szerző szerint "Müller, Judit"

Keresés

Tallózás

Teljes repozitórumban

Hozzáférésem